Short-term follow-up results of drug-eluting stenting in premature coronary artey disease patients with multiple atherosclerotic risk factors

Journal of the Chinese Medical Association

Volumn 71, Issue 7, 2008, Pages 342-346

  Wang, Ming Hsiung ^a,b   Lee, Wee Lieng ^a,c   Wang, Kuo Yang ^a,d   Hsieh, Yu Cheng ^a,c   Liu, Tsun Jui ^a,c   Lin, I Hsiang ^a,e   Lin, Wei Wen ^a   Ting, Chih Tai ^a,c   Liang, Kae Woei ^a,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b FENG YUAN HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e Nantou Hospital   (Taiwan)

Author keywords

Acute coronary syndrome; Coronary artey disease; Drug eluting stent; Familial hypercholesterolemia; Premature CAD

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; MALE; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; THROMBOSIS; TREATMENT OUTCOME;

EID: 50049128474     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70136-9     Document Type: Article

References (22)

1. Jalowiec DA, Hill JA. Myocardial infarction in the young and in women. Cardiovasc Clin 1989;20:197-206.
2. Klein LW, Nathan S. Coronary artery disease in young adults. J Am Coll Cardiol 2003;41:529-31.
3. Juan CC, Hwang B, Lee PC, Lin YJ, Chien JC, Lee MY, Meng CC. The clinical manifestations and risk factors of a delayed diagnosis of Kawasaki disease. J Clin Med Assoc 2007;70:374-9.
4. Fong MC, Chen KC, Leu HB, Chen LC. Coronary revascularization in a patient with immune thrombocytopenic purpura. J Chin Med Assoc 2006;69:436-8.
5. Lai CC, Hsiao HC, Hsiao SH, Huang WC, Chiou CW, Yeh TC, Hwang HR, et al. Role of shortened QTc dispersion in in-hospital cardiac events in patients undergoing percutaneous coronary intervention for acute coronary syndrome. J Chin Med Assoc 2006;69:297-303.
6. Hsiao HC, Chen CH, Kong CW, Liu CP. Acute effects of dual-chamber pacing on the left ventricular systolic function and relaxation in patients with advanced AV block and sick sinus syndrome. J Chin Med Assoc 2006;69:32-6.
7. Liang KW, Lee WL, Hsueh CW, Chen YT, Ting CT. Atrial demand pacemakers in sick sinus syndrome: an efficient and reliable approach in selected patients. J Chin Med Assoc 2003;66:709-14.
8. Wong WW, Chen TL, Yang SP, Wang FD, Cheng NC, Kuo BI, Yu KW, et al. Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei. J Chin Med Assoc 2003;66:323-7.
9. Holbrook JH, Grundy SM, Hennekens CH, Kannel WB, Strong JP. Cigarette smoking and cardiovascular diseases: statement for health professionals by a task force appointed by the Steering Committee of the American Heart Association. Circulation 1984;70:1114A-7A.
10. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987;113:1006-10.
11. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
12. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
13. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial - a randomized controlled trial. JAMA 2006;295:895-904.
14. Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005;112:3306-13.
15. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-23.
16. Cole JH, Miller JI 3rd, Sperling LS, Weintraub WS. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol 2003;41:521-8.
17. Mauri L, Hsieh WH, Maasaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9.
18. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356: 998-1008.
19. Schuster H. High risk/high priority: familial hypercholesterolemia - a paradigm for molecular medicine. Atherosclerosis 2002;(Suppl 2):27-32.
20. Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004; 173:55-68.
21. van't Hof AW, de Boer MJ, Suryapranata H, Hoorntje JC, Zijlstra F. Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: the importance of age and procedural result. Am Heart J 1998;136:518-27.
22. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-16.